Lilly(Eli) & Company

NYSE: LLY
$887.16
+$1.61 (+0.2%)
Closing Price on October 4, 2024

LLY Articles

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the sentiment may be less than stellar now, massive drug pricing changes...
In a new research report, Credit Suisse highlighted some companies on its U.S. Focus List that stand to have the most potential price return.
These four solid companies to buy and hold all can do well, and even if the market sells off, the demand for their products and services will not. Plus, they all offer a dividend.
24/7 Wall St. has identified seven companies that could easily reach the $100 billion mark to become the next mega-cap stocks.
March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped...
March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more...
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend leader is now the top pick globally.
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.
24/7 Wall St. screened the Merrill Lynch research universe database and found four outstanding dividend stocks that are rated Buy and also offer tremendous value now.
24/7 Wall St. screened the list of the top Merrill Lynch picks for the dividend yielding stocks that are on sale and found four outstanding ones to buy now.
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and...